Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis

Recruiting Observational Study
Ulcerative Colitis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 17
Sex
Any
Study type
Observational
Participants needed
80 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Ulcerative Colitis (UC) is a chronic Inflammatory Bowel Disease characterized by chronic inflammation of the colon. Composition of gut microbiota of UC patients is abnormal (dysbiosis). Ulcerative Colitis patients have an increased risk of Clostridioides difficile infection (CDI) and CDI complications (colectomy, death, recurrence). The reason for this increased risk in IBD patients is not fully …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
For everyone : Inclusion Criteria: * Pediatric patients (\<18 years) consultant or hospitalized in the Gastroenterology department of Necker-Enfants Malades Hospital. * Information and consent of parents and the patient Exclusion Criteria: * Patient who received antibiotic or antifungal treatmen…
Contacts

Bénédicte Pigneur, MD

1 44 49 25 16

benedicte.pigneur@aphp.fr

CONTACT

Hélène Morel

1 71 19 63 46

helene.morel@aphp.fr

CONTACT